PF-Atlas › Clinical Trials › NCT00000990
The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms
Zidovudine · Phase 2
Registry ID
NCT00000990
Phase
Phase 2
Status
Completed
Drug / intervention
Zidovudine
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
About this trial
Zidovudine is evaluated in NCT00000990, a Phase 2 idiopathic pulmonary fibrosis study sponsored by National Institute of Allergy and Infectious Diseases (NIAID). Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00000990 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.